Neurogenic Orthostatic Hypotension
📧 Sign up to get email alerts when something new happens for Neurogenic Orthostatic Hypotension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-11-01FDA Approved: DROXIDOPA — Original Application (Slate Run Pharmaceuticals, LLC)
The FDA approved the original application for droxidopa from Slate Run Pharmaceuticals, LLC, enabling its market authorization for treating …
-
FDA approval · 2021-04-28FDA Approved: DROXIDOPA — Original Application (Bionpharma Inc.)
FDA approved the original application for a generic version of droxidopa, with Bionpharma Inc. as the manufacturer. The drug is used to trea…
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (ScieGen Pharmaceuticals Inc)
FDA approved the original application for droxidopa from ScieGen Pharmaceuticals Inc to treat symptomatic neurogenic orthostatic hypotension…
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic droxidopa (DROXIDOPA) under an Original Application (ANDA211726).
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original application for droxidopa from Zydus Pharmaceuticals USA Inc., making a generic version of the drug available.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic droxidopa product under an original application (ANDA 211652).
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of droxidopa under an Original Application (ANDA 214387) from Aurobindo Pharma Limited.
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (CivicaScript LLC)
FDA approved the original application for droxidopa (generic) by CivicaScript LLC to treat neurogenic orthostatic hypotension.
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original application for droxidopa (DROXIDOPA) for Novadoz Pharmaceuticals LLC.
-
FDA approval · 2021-02-18FDA Approved: DROXIDOPA — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original application for droxidopa, granting approval of a generic version of the drug. Droxidop…
-
FDA approval · 2020-10-01FDA Approved: MIDODRINE HYDROCHLORIDE — Original Application (Xiromed, LLC)
FDA approved Midodrine Hydrochloride under an original Abbreviated New Drug Application (ANDA) for Xiromed, LLC.
-
FDA approval · 2019-11-04FDA Approved: MIDODRINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Midodrine hydrochloride submitted by Mylan Pharmaceuticals Inc.
-
FDA approval · 2017-02-10FDA Approved: NORTHERA — Supplemental Application (Lundbeck Pharmaceuticals LLC)
The FDA approved a supplemental application for Northera (droxidopa) submitted by Lundbeck Pharmaceuticals LLC. This action approves changes…
-
FDA approval · 2015-08-24FDA Approved: NORTHERA — Supplemental Application (Lundbeck Pharmaceuticals LLC)
The FDA approved a supplemental application for NORTHERA (droxidopa) from Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2015-08-19FDA Approved: NORTHERA — Supplemental Application (Lundbeck Pharmaceuticals LLC)
The FDA approved a supplemental application for NORTHERA (droxidopa) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2014-09-30FDA Approved: NORTHERA — Supplemental Application (Lundbeck Pharmaceuticals LLC)
The FDA approved a supplemental application for NORTHERA (droxidopa) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2014-02-18FDA Approved: NORTHERA — Original Application (Lundbeck Pharmaceuticals LLC)
The FDA approved NORTHERA (droxidopa) through an original NDA submitted by Lundbeck Pharmaceuticals LLC. It is indicated for the treatment o…